2012 annual financial data
Viridian Therapeutics 2012 Operating margin
Viridian Therapeutics 2012 operating margin with verified reported values.
Direct answer
Operating margin was -91.4%.
Operating income was -4,027,000 USD and net income was -7,211,285 USD.
Operating cash flow was -6,224,802 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,406,042 USD
- Operating income
- -4,027,000 USD
- Net income
- -7,211,285 USD
- Operating cash flow
- -6,224,802 USD